Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. [electronic resource]
Producer: 20150928Description: 848-58 p. digitalISSN:- 1474-5488
- Administration, Oral
- Adult
- Antineoplastic Agents, Hormonal -- adverse effects
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Early Detection of Cancer
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Ovary -- drug effects
- Premenopause -- physiology
- Quality of Life
- Risk Assessment
- Self Report
- Survival Analysis
- Tamoxifen -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.